BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11134277)

  • 1. Ty1 proteolytic cleavage sites are required for transposition: all sites are not created equal.
    Merkulov GV; Lawler JF; Eby Y; Boeke JD
    J Virol; 2001 Jan; 75(2):638-44. PubMed ID: 11134277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ty1 defect in proteolysis at high temperature.
    Lawler JF; Haeusser DP; Dull A; Boeke JD; Keeney JB
    J Virol; 2002 May; 76(9):4233-40. PubMed ID: 11932388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
    Stewart L; Vogt VM
    J Virol; 1991 Nov; 65(11):6218-31. PubMed ID: 1717719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical proteolytic cleavage site near the C terminus of the yeast retrotransposon Ty1 Gag protein.
    Merkulov GV; Swiderek KM; Brachmann CB; Boeke JD
    J Virol; 1996 Aug; 70(8):5548-56. PubMed ID: 8764068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
    Stewart L; Vogt VM
    Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.
    Craven RC; Bennett RP; Wills JW
    J Virol; 1991 Nov; 65(11):6205-17. PubMed ID: 1717718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshift signal transplantation and the unambiguous analysis of mutations in the yeast retrotransposon Ty1 Gag-Pol overlap region.
    Lawler JF; Merkulov GV; Boeke JD
    J Virol; 2001 Aug; 75(15):6769-75. PubMed ID: 11435555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of proteolytic cleavage sites within the gag-analogue protein of Ty1 virus-like particles.
    Martin-Rendon E; Hurd DW; Marfany G; Kingsman SM; Kingsman AJ
    Mol Microbiol; 1996 Dec; 22(5):1035-43. PubMed ID: 8971723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.
    Xiang Y; Ridky TW; Krishna NK; Leis J
    J Virol; 1997 Mar; 71(3):2083-91. PubMed ID: 9032340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers.
    Burstein H; Bizub D; Skalka AM
    J Virol; 1991 Nov; 65(11):6165-72. PubMed ID: 1656090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.
    Schatz G; Pichova I; Vogt VM
    J Virol; 1997 Jan; 71(1):444-50. PubMed ID: 8985369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between reverse transcriptase and integrase during reverse transcription and formation of the preintegrative complex of Ty1.
    Wilhelm M; Wilhelm FX
    Eukaryot Cell; 2006 Oct; 5(10):1760-9. PubMed ID: 17031000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants.
    Oertle S; Bowles N; Spahr PF
    J Virol; 1992 Jun; 66(6):3873-8. PubMed ID: 1316486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ty1 Retrotransposon Restriction Factor p22 Targets Gag.
    Tucker JM; Larango ME; Wachsmuth LP; Kannan N; Garfinkel DJ
    PLoS Genet; 2015 Oct; 11(10):e1005571. PubMed ID: 26451601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian sarcoma leukemia virus protease linked to the adjacent Gag polyprotein is enzymatically active.
    Arad G; Bar-Meir R; Almog N; Chorev M; Kotler M
    Virology; 1995 Dec; 214(2):439-44. PubMed ID: 8553545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of Ty1 retrotransposon protease.
    Gazda LD; Joóné Matúz K; Nagy T; Mótyán JA; Tőzsér J
    PLoS One; 2020; 15(1):e0227062. PubMed ID: 31917798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleocapsid functionality contained within the amino terminus of the Ty1 protease that is distinct and separable from proteolytic activity.
    Lawler JF; Merkulov GV; Boeke JD
    J Virol; 2002 Jan; 76(1):346-54. PubMed ID: 11739699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ty1 gag enhances the stability and nuclear export of Ty1 mRNA.
    Checkley MA; Mitchell JA; Eizenstat LD; Lockett SJ; Garfinkel DJ
    Traffic; 2013 Jan; 14(1):57-69. PubMed ID: 22998189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trans-dominant form of Gag restricts Ty1 retrotransposition and mediates copy number control.
    Saha A; Mitchell JA; Nishida Y; Hildreth JE; Ariberre JA; Gilbert WV; Garfinkel DJ
    J Virol; 2015 Apr; 89(7):3922-38. PubMed ID: 25609815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.